Janet Kelske
Registered Nurse · West Bay Shore, NYNPI 1083663413
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 209 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Among registered nurse clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 209 payments — averaging $26.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$1K
- AstraZeneca$1K
- GSK$523
- Incyte Corporation$315
- Sanofi$271
- Amgen$256
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,37596%
- Education$2464%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 43 | $1,179 |
| AstraZeneca | 23 | $1,010 |
| GSK | 27 | $523 |
| Incyte Corporation | 10 | $315 |
| Sanofi | 7 | $271 |
| Amgen | 8 | $256 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $251 |
| Optinose US, Inc. | 12 | $218 |
| Sanofi-aventis U.S. LLC | 2 | $157 |
| CSL Behring | 2 | $144 |
| Genentech USA, Inc. | 6 | $144 |
| Kaleo, Inc. | 8 | $140 |
| Aytu Biopharma, Inc. | 7 | $127 |
| Pfizer | 6 | $112 |
| Pharming Healthcare, Inc. | 1 | $107 |
| Novartis | 5 | $104 |
| AbbVie | 4 | $91 |
| LEO Pharma Inc. | 3 | $77 |
| Alk-abello, Inc | 4 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Octapharma USA, Inc. | 2 | $47 |
| Grifols USA, LLC | 2 | $43 |
| Hikma Pharmaceuticals USA | 2 | $43 |
| Lilly USA, LLC | 2 | $42 |
| Blueprint Medicines Corporation | 2 | $37 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $32 |
| Neos Therapeutics, LP | 1 | $17 |
| Biocryst US Sales Co., LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,621 in reported general payments places this provider in the 95th percentile of 446 registered nurse providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 13 | $44,641 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $30,560 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $8,316 |
| Epinephrine | 18 | $2,541 |
| Mometasone Furoate | 23 | $1,714 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,621 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $1,570 |
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 12 | $862 |
| Levocetirizine Dihydrochloride | 36 | $566 |
| Montelukast Sodium | 49 | $404 |
| Hydroxyzine Hcl | 14 | $150 |
| Azithromycin | 22 | $141 |
| Famotidine | 15 | $105 |
| Prednisone | 27 | $39 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $523 | $38,87641 claims |
| Hikma Pharmaceuticals USAEpinephrine | $43 | $2,54118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 446 registered nurse providers in New York.
Other registered nurse in West Bay Shore
- Jane SeleyNew York$20K
- Chia-Wei LinBronx$15K
- Cathleen VarleyNew York$13K
- Hyojin KangOakland Gardens$7K
- Barbara RysWarwick$7K
- Kathleen Foley RootSmithtown$5K
- Lisa Desjardins-RitchieGreat Neck$4K
- Hilary NierenbergNew York$4K
- Sharon JasekSyracuse$3K
- Sandra BastidasPort Washington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.